Sacubitril/valsartan (LCZ696) reduces myocardial injury following myocardial infarction by inhibiting NLRP3‑induced pyroptosis via the TAK1/JNK signaling pathwayJianfen Shen, Guoxian Qi|Molecular Medicine Reports|2021Cited by 35
<p>AdipoRon Alleviates Free Fatty Acid-Induced Myocardial Cell Injury Via Suppressing Nlrp3 Inflammasome Activation</p>You‐Zhi Zhang, Jianfen Shen|Diabetes Metabolic Syndrome and Obesity|2019Cited by 26
The synergistic effect of 2,3,5,4&prime;-Tetrahydroxystilbene-2-O-&beta;-D-glucoside combined with Adriamycin on MCF-7 breast cancer cellsJianfen Shen, Zhiying Ding, Longsheng Xu et al.|Drug Design Development and Therapy|2018Cited by 11
Sacubitril Valsartan Enhances Cardiac Function and Alleviates Myocardial Infarction in Rats through a SUV39H1/SPP1 AxisJianfen Shen, Feng Xu|Oxidative Medicine and Cellular Longevity|2022Cited by 9